Overview


According to FutureWise analysis the market for Paromomycin Sulfate is expected to register a CAGR of 5.70% from 2023-2031.

An antimicrobial called paromomycin is used to treat parasitic infections such as amebiasis, giardiasis, leishmaniasis, and tapeworm infection. Amebiasis or giardiasis during pregnancy can be treated with it as a first-line treatment. Other than that, it is generally considered a second-line treatment. The medication is taken orally, applied topically, or injected intramuscularly. There are several common side effects associated with taking this medication by mouth, including loss of appetite, vomiting, abdominal pain, and diarrhea. Itchy skin, redness, and blisters are some of the side effects when applied to the skin. There is the possibility of fever, liver problems, and hearing loss when given by injection. There are no known risks associated with breastfeeding. By stopping bacterial protein synthesis, paromomycin belongs to the aminoglycoside family of medications. As a result of treating paromomycin with sulfuric acid, paromomycin sulfate is an aminoglycoside sulfate salt. A type of antimicrobial medicine used to treat acute and chronic intestinal amoebiasis. As a result of the presence of parasitic organisms in the intestines or stomach, amebiasis is a bowel infection. Additionally, it is used to treat various parasitic infections such as giardiasis, leishmaniasis, and tapeworms. Additionally, this medicine is used with other drugs to relieve the symptoms of hepatic coma, a complicated liver disease. A certain parasite infection of the intestines (amebiasis) is treated with this medication. Antibiotics that contain aminoglycosides are known as aminoglycosides. Through its effects on parasite growth, it stops the growth of parasites in the intestines. Because this medication is poorly absorbed into the blood, it will not work for infections outside of the intestines. A special diet and paromomycin may also be used to treat a serious brain problem (hepatic encephalopathy). An excessive amount of a certain natural substance (ammonia) in the body causes this condition to occur in people with liver disease. Ammonia is normally excreted by the liver. By stopping the growth of certain bacteria in your intestines that produce ammonia, paromomycin treats hepatic encephalopathy. Infections caused by parasites and bacteria are the only types of infections treated by this antibiotic. Infections caused by viruses (such as the common cold and flu) will not be treated with it. The effectiveness of any antibiotic can be decreased if it is used or misused unnecessarily.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Paromomycin Sulfate Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Paromomycin Sulfate Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Pfizer
  • Changrui Pharm
  • ERFA Canada
  • Shanhe Pharm
  • Kaifeng Pharm

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • 99% Purity
  • 96% Purity

By Application

  • Paromomycin Sulfate
  • Paromomycin Injection

By Distribution Channel

  • Retail Pharmacies
  • Online Drug Stores
  • Hospital Pharmacies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Paromomycin Sulfate Market By Type, By Application, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Paromomycin Sulfate Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Paromomycin Sulfate Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Paromomycin Sulfate Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Paromomycin Sulfate Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 99% Purity
        2. 96% Purity

  • 8.   Paromomycin Sulfate Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Paromomycin Sulfate
        2. Paromomycin Injection

  • 9.   Paromomycin Sulfate Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Retail Pharmacies
        2. Online Drug Stores
        3. Hospital Pharmacies
        4. Others

  • 10.   North America Paromomycin Sulfate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Paromomycin Sulfate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Paromomycin Sulfate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Paromomycin Sulfate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Paromomycin Sulfate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Changrui Pharm
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. ERFA Canada
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Shanhe Pharm
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Kaifeng Pharm
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients